Video-based screening for preschoolers' gross motor development
Official title: Video-based Assessment of Preschool Children's Gross Motor Development for Early Intervention Screening
Run by Chang Gung Memorial Hospital · NCT07054437 · Data updated 2026-11-12
This project will try using clinic videos and AI to screen gross motor development in children aged 1 to 6 who can walk, to make assessments faster and easier.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Year to 6 Years |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Chang Gung Memorial Hospital Academic / other |
| Locations | 1 site (Taoyuan) |
| Status | Recruiting |
| Started | June 11, 2025 |
| Main results expected | June 11, 2026 |
| Study ends | August 31, 2026 |
| Registry record updated | July 8, 2025 |
| Trial ID | NCT07054437 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are native Chinese–speaking children aged 1 to 6 who can walk independently and whose legal guardian can provide written consent and attend the Linkou site.
✕Probably not a fit
Children who cannot walk independently, are outside the 1–6 age range, or are non-native Chinese speakers are unlikely to benefit from this specific screening tool.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project will collect video recordings of independently walking children aged 1–6 at Linkou Chang Gung Memorial Hospital and apply machine learning and neural network methods to build an automated gross motor screening tool. Models will be trained on annotated videos using established clinical motor-development norms and compared with standard evaluator observations. The workflow is intended to reduce the time and human resources needed for on-site visual assessment by automating parts of the screening process. Guardians provide written consent and non-native Chinese speakers are excluded to match the study's language and cultural validation needs.
Why it matters
Potential benefit: If successful, the tool could speed up early detection of motor delays and reduce reliance on specialist time, enabling earlier referral to intervention services.
How similar studies have gone: Prior pilot studies applying AI to pediatric motor assessment have shown promising accuracy, but such approaches remain experimental and need local validation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Legal guardian willing to provide written informed consent. * Males and females aged 1 to 6 years old. * Capable of independent walking. Exclusion Criteria: \- Non-native Chinese speakers.
Where it's running
-
Linkou Chang Gung Memorial Hospital
Taoyuan, Taiwan Recruiting
Study contacts
- Study coordinator: yijing li
- Email: yjl9528@gmail.com
- Phone: +886-920226108
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
-
Heart rate variability biofeedback, mindfulness, or psychoeducation after knee replacement
This trial tests whether heart rate variability biofeedback, mindfulness, or psychoeducation help people recover better after total knee arthroplasty.
-
Intelligent Sexual Health Help System for Gynecologic Cancer Patients
A smartphone-based sexual health education and consultation system called LillyBot will be tested with gynecologic cancer patients to see if it improves sexual well-being.
-
Hyperpolarized 13C-MMRI and Metabolomics in Rectal Cancer
This study tests whether a special MRI method and metabolic analysis can better predict how rectal cancer responds to chemoradiotherapy.
-
Dry Cord Care vs Alcohol Cord Care for Healthy Newborns
This trial tests whether dry cord care or routine alcohol cord care is better for healthy newborns by looking at infection rates in the umbilical cord.
-
Dinutuximab-beta with chemotherapy in newly diagnosed high-risk neuroblastoma
This pilot study tests whether adding the antibody dinutuximab-beta to standard induction chemotherapy is safe and helps shrink tumors in kids and young adults with newly diagnosed high-risk neuroblastoma.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.